One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center...
The vaccine is more than 75% effective among subjects under the age of 60. Sputnik Light also provides much higher efficacy against severe disease and hospitalizations. Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decline in efficacy against the Delta variant to less than 50% five months after...
Gannex Announces Clinical and Preclinical Data of Four NASH Programs to be Presented in Oral or Poster Presentation at The Liver Meeting® 2021 by American Association for the Study...
SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672), announces today that the latest clinical and preclinical data of four NASH programs (ASC40/TVB-2640 co-authored with Sagimet Biosciences Inc., ASC41, ASC42 and ASC43F) will be presented in oral or poster presentation at The Liver Meeting® 2021 of American Association for the...
Berry Oncology Releases Latest Research Results on Early Screening for Multiple Cancers
SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Berry Oncology, a Chinese oncology genomic testing company, was invited to the inaugural International Biopharma Industry Week in Shanghai (IBIWS) running from October 11-14, where CEO Jun Zhou delivered a much-anticipated keynote speech at the "2021 Future Healthcare Industry Summit" subforum, unveiling the company's latest research results on early screening for multiple cancers. The advanced...
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China
Completed patient enrollment in phase 3 registrational trial of felzartamab in combination with lenalidomide for second-line treatment of multiple myeloma (MM) Felzartamab for MM third-line treatment is on track for BLA submission in Q4 2021 New IND application for combination of felzartamab with another I-Mab clinical asset as a...
Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt
JIUQUAN, China, Oct. 13, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that on September 14, 2021, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. (the "Gansu QLS"), it has received Certificate of a Pharmaceutical Product (the "Export Certificate") from Gansu Province Drug Administration, which approves the export of its Qilian Shan® Oxytetracycline APIs (Active Pharmaceutical Ingredients)...
Shanghai, industry partners to co-build world-class biopharma industry cluster
SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- This is a report from China.org.cn: The 2021 International Biopharma Industry Week opened in Shanghai on Oct. 11, bringing together industry gurus, research minds, investors, and government representatives to discuss the latest trends in the biopharmaceutical sector and drive new growth momentum. The four-day industry gathering, featuring an opening ceremony and 20 forums...
The CDE Approved IND Application to Investigate Combination of Asieris’ APL-1202 and BeiGene’s Tislelizumab as Neoadjuvant Therapy for MIBC Patients
SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris) today announced that the Center for Drug Evaluation (CDE) NMPA has approved the Investigational New Drug (IND) application of oral APL-1202 in combination with BeiGene's tislelizumab as neoadjuvant therapy in patients with muscle invasive bladder cancer (MIBC). This IND was already cleared by the U.S. Food and Drug Administration (FDA)...
Increasing Demand for Premium Dietary Options Fueling the Global Pet Food Ingredients Market
Growing consciousness of pet health and wellness pushes the growth of functional and specialized ingredients SAN ANTONIO, Oct. 13, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global pet food ingredients industry finds that pet owners' growing emphasis on the quality of their pet's diet is inflating the demand for premium pet food. This is driving the global...
World Thrombosis Day Campaign Unites Thousands of Global Partners to Shine a Spotlight on Blood Clots as an Urgent Health Problem
In its Eighth Year, the Global Campaign Aims to Increase Public Awareness of Blood Clots that Result from Hospitalization and COVID-19 CHAPEL HILL, N.C., Oct. 13, 2021 /PRNewswire/ -- Today, the World Thrombosis Day campaign encourages the public, healthcare professionals and policy makers to keep their "Eyes Open to Thrombosis" and join together...
Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America
SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Gilead Sciences, Inc. today announced its partnership with IAS - the International AIDS Society - to expand the Me & My Healthcare Provider campaign to three locations in Asia: Hong Kong; South Korea; and Taiwan and renew the program in two locations in Latin America: Brazil and Mexico. The campaign promotes best practices in...
